Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK), a Cayman Islands emerging growth company, filed this Form 8-K on September 3, 2026. The filing reports the extension of the company's termination date for consummating its initial business combination.
Key Financial Metrics
The filing details a specific financial obligation related to the extension of the business combination timeline:
- Extension Payment: $34,330.96 deposited into the trust account for public shareholders.
- Promissory Note Issued: $34,330.96 principal amount issued to Aimei Investment Ltd.
- Interest Rate: 0% (non-interest bearing).
- Conversion Price: $10.00 per private unit (one ordinary share and one right) if converted prior to the business combination.
The filing does not provide data on revenue, profit, cash flow, margins, or overall liquidity beyond the specific extension transaction.
Material Changes
The primary material change is the extension of the Termination Date from September 6, 2026, to October 6, 2026. This represents the 22nd extension permitted under the company's Amended and Restated Articles of Association. The company has incurred a new direct financial obligation via the issuance of the unsecured promissory note to fund the extension payment.
Outlook, Risks, and Contingencies
Business Combination: The company is pursuing a business combination with United Hydrogen. The promissory note becomes due and payable upon the consummation of this transaction.
Contingencies: The Payee (Aimei Investment Ltd.) has the right, but not the obligation, to convert the promissory note into private units immediately prior to the closing of the business combination, provided written notice is given at least two business days prior to closing.
Risks: The filing implies a risk of liquidation if the business combination is not consummated by the new termination date of October 6, 2026, as this is the final permitted extension.
Investor Verification Checklist
- Verify the status of the proposed business combination with United Hydrogen.
- Confirm the total number of outstanding public shares to validate the $34,330.96 extension payment calculation.
- Review the full text of the Promissory Note (Exhibit 10.1) for additional covenants or conditions not summarized in the 8-K.
- Monitor whether the Payee elects to convert the note into equity prior to the closing of the business combination.